Vivos Therapeutics (VVOS) Selling, General & Administrative (2020 - 2026)
Vivos Therapeutics (VVOS) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 4.03 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 2.23 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 1.80 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 561.20 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 358.70 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 1.12 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -179.00 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 369.70 Mn |
| 10 | Vivos Therapeutics | 4.95 Mn | 3.15 Mn | 2.95 Mn | 7.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.97 Mn |
| Dec 31, 2025 | 8.55 Mn |
| Sep 30, 2025 | 7.88 Mn |
| Jun 30, 2025 | 6.41 Mn |
| Mar 31, 2025 | 4.89 Mn |
| Dec 31, 2024 | 4.35 Mn |
| Sep 30, 2024 | 4.49 Mn |
| Jun 30, 2024 | 4.12 Mn |
| Mar 31, 2024 | 4.92 Mn |
| Dec 31, 2023 | 5.47 Mn |
| Sep 30, 2023 | 4.60 Mn |
| Jun 30, 2023 | 5.88 Mn |
| Mar 31, 2023 | 6.54 Mn |
| Dec 31, 2022 | 6.92 Mn |
| Sep 30, 2022 | 6.62 Mn |
| Jun 30, 2022 | 7.69 Mn |
| Mar 31, 2022 | 8.28 Mn |
| Dec 31, 2021 | 8.12 Mn |
| Sep 30, 2021 | 6.52 Mn |
| Jun 30, 2021 | 6.09 Mn |